ASPHO 2022

Obinutuzumab With ICE Chemotherapy Well-Tolerated in Young Patients With Burkitt Lymphoma

Researchers sought to determine whether chemoimmunotherapy with obinutuzumab, ifosfamide, carboplatin, and etoposide would be effective in young patients with Burkitt lymphoma.

Mitoxantrone and Clofarabine Reinduction for Pediatric Patients With Leukemia

Researchers sought to determine whether a reinduction therapy approach using mitoxantrone with clofarabine would be safe and effective for pediatric patients with leukemia.

Delays in Initiation of Revaccination in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplant

Researchers sought to determine the effect of transplant-related complications and socioeconomic factors on revaccination schedule adherence among pediatric patients following allo-HSCT.

Real-World Outcomes of Tisagenlecleucel in Patients Younger Than 3 Years With Acute Lymphoblastic Leukemia

Researchers sought to determine whether tisagenlecleucel is safe and effective in patients younger than 3 years old with relapsed/refractory ALL.

Opioid Restriction Associated With Poor Outcomes in Patients With Sickle Cell Disease

Researchers sought to evaluate the effect of the CDC’s guideline on opioid prescriptions and health outcomes on patients with SCD.

Serum Asparaginase Activity Level Measurement Recommended in Infants With Acute Lymphoblastic Leukemia

Researchers sought to determine whether monitoring SAA levels would be a helpful strategy for determining therapy efficacy in infants with ALL.

Emicizumab Safe, Effective in Patients With Hemophilia A With FVIII Inhibitors

Researchers sought to determine whether emicizumab would be safe and effective in pediatric patients with hemophilia A with FVIII inhibitors.